Status:
COMPLETED
Predicting Aneurysm Growth and Rupture With Longitudinal Biomarkers
Lead Sponsor:
Ron Balm
Conditions:
Abdominal Aortic Aneurysm
Abdominal Aortic Aneurysm, Ruptured
Eligibility:
All Genders
18+ years
Brief Summary
First aim: PARIS study The main aim of the current study is to determine the association between abdominal aortic aneurysm (AAA) progression and the evolution of proteases and cytokines levels.To ach...
Detailed Description
The PARIS study aims to determine the correlation between AAA progression (growth or rupture) and the evolution of serum levels of proteases and cytokines over time. A repeated measures analysis will ...
Eligibility Criteria
Inclusion
- Adult participant (18 years or older)
- Participant has an AAA or has previously been treated for an AAA
- Adequate comprehension of the Dutch language to provide written informed consent
Exclusion
- A patient who is decisionally impaired. The only exception to this are the patients who are decisionally impaired due to the effects of an acute AAA. This particular group is eligible for which a separate recruitment and consent procedure exists.
Key Trial Info
Start Date :
October 4 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 4 2023
Estimated Enrollment :
790 Patients enrolled
Trial Details
Trial ID
NCT03320408
Start Date
October 4 2017
End Date
August 4 2023
Last Update
August 22 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center (LUMC)
Leiden, South Holland, Netherlands, 2333ZA
2
Department of Vascular Surgery, Amsterdam UMC, location AMC
Amsterdam, Netherlands, 1105 AZ